0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Prescribing Behavior
 1-20 of 130 Articles
Viewpoint |  FREE ONLINE FIRST
Sidney M. Wolfe, MD
JAMA Intern Med. Published online August 15, 2014. doi:10.1001/jamainternmed.2014.4547

Editor's Note | 
Joseph S. Ross, MD, MHS
JAMA Intern Med. 2014;174(8):1290. doi:10.1001/jamainternmed.2014.1862.

Original Investigation | 
Kirsten E. Austad, MD; Jerry Avorn, MD; Jessica M. Franklin, PhD; et al.
JAMA Intern Med. 2014;174(8):1283-1290. doi:10.1001/jamainternmed.2014.2202.
Includes: Supplemental Content

Perspective | 
Avery MacKenzie, MD
JAMA Intern Med. 2014;174(8):1221-1222. doi:10.1001/jamainternmed.2014.2124.

Invited Commentary | 
David M. Shahian, MD
JAMA Intern Med. 2014;174(8):1328-1329. doi:10.1001/jamainternmed.2014.155.

Perspective | 
Timothy Sullivan, MD
JAMA Intern Med. 2014;174(8):1219-1220. doi:10.1001/jamainternmed.2014.2299.

Research Letter |  ONLINE FIRST
Jonathan M. Wortham, MD; Daniel J. Shapiro, BA; Adam L. Hersh, MD, PhD; et al.
JAMA Intern Med. Published online July 28, 2014. doi:10.1001/jamainternmed.2014.3456

Perspective | 
Carla Carnovale, PharmD; Mauro Venegoni, MD; Emilio Clementi, MD, PhD
JAMA Intern Med. 2014;174(7):1031-1032. doi:10.1001/jamainternmed.2014.1427.

Perspective | 
Nicholas J. Rohrhoff, MD; Diana B. McNeill, MD; Joel C. Boggan, MD, MPH
JAMA Intern Med. 2014;174(7):1035-1036. doi:10.1001/jamainternmed.2014.1605.

Viewpoint | 
Gurpreet Dhaliwal, MD
JAMA Intern Med. 2014;174(7):1021-1022. doi:10.1001/jamainternmed.2014.2012.

Original Investigation | 
Cara Tannenbaum, MD, MSc; Philippe Martin, BSc; Robyn Tamblyn, PhD; et al.
JAMA Intern Med. 2014;174(6):890-898. doi:10.1001/jamainternmed.2014.949.
Includes: CME, Supplemental Content

Viewpoint | 
Scott A. Flanders, MD; Sanjay Saint, MD, MPH
JAMA Intern Med. 2014;174(5):661-662. doi:10.1001/jamainternmed.2014.897.

Research Letter | 
Christopher M. Jones, PharmD, MPH; Leonard J. Paulozzi, MD, MPH; Karin A. Mack, PhD
JAMA Intern Med. 2014;174(5):802-803. doi:10.1001/jamainternmed.2013.12809.

Original Investigation | 
Jane A. Gwira Baumblatt, MD; Caleb Wiedeman, MPH; John R. Dunn, DVM, PhD; et al.
JAMA Intern Med. 2014;174(5):796-801. doi:10.1001/jamainternmed.2013.12711.

Invited Commentary | 
Brad Spellberg, MD
JAMA Intern Med. 2014;174(3):432-433. doi:10.1001/jamainternmed.2013.14019.

Original Investigation | 
Daniella Meeker, PhD; Tara K. Knight, PhD; Mark W. Friedberg, MD, MPP; et al.
JAMA Intern Med. 2014;174(3):425-431. doi:10.1001/jamainternmed.2013.14191.

Research Letter | 
Michael L. Barnett, MD; Jeffrey A. Linder, MD, MPH
JAMA Intern Med. 2014;174(1):138-140. doi:10.1001/jamainternmed.2013.11673.

Original Investigation | 
Peter N. Taylor, MSc, MRCP; Ahmed Iqbal, MRCP; Caroline Minassian, MSc; et al.
JAMA Intern Med. 2014;174(1):32-39. doi:10.1001/jamainternmed.2013.11312.
Includes: Supplemental Content

Original Investigation | 
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA Intern Med. 2014;174(1):90-95. doi:10.1001/jamainternmed.2013.11813.

Research Letter | 
Zachary D. Goldberger, MD, MS; G. Caleb Alexander, MD, MS
JAMA Intern Med. 2014;174(1):151-154. doi:10.1001/jamainternmed.2013.10432.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Medical News & Perspectives  | 
CDC: Major Disparities in Opioid Prescribing Among States:  Some States Crack Down on Excess Prescribing
Bridget M. Kuehn, MSJ
JAMA Neurology
Editorial  | 
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
Olaf Stüve, MD, PhD; Gary R. Cutter, PhD
JAMA Neurology
Original Investigation  | 
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab:  Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study)
Marinella Clerico, MD; Irene Schiavetti, BS; Stefania F. De Mercanti, MD; et al.
JAMA
Special Communication  | 
Antiretroviral Treatment of Adult HIV Infection:  2014 Recommendations of the International Antiviral Society–USA Panel
Huldrych F. Günthard, MD; Judith A. Aberg, MD; Joseph J. Eron, MD; et al.